Insider Transactions

Michael Mahoney, a director at CVS Health (CVS), recently bought 30,000 shares. The buy increased his position by a massive 190%, and came to a total cost of just over $2 million. Mahoney was a buyer of over 9,100 shares last May, for just over $500,000. Another director also picked up 1,000 shares around the same period. Going back further, insiders were equally buyers and sellers of shares at a price near where CVS shares trade today. Overall, CVS Health insiders own ...
Read More About This

Philip Satre, a director at Wynn Resorts (WYNN), recently bought 22,200 shares. The buy increased his stake by a hefty 67%, and came to a total cost of just over $2.04 million. This marks the first insider buy at Wynn over the past two years. Insiders have been slight sellers of shares, with about half of sales occurring following the exercise of stock options. Sales include the company CEO and CFO. Overall, Wynn Resorts insiders own 27.1% of shares. The resort owner and ...
Read More About This

Christopher Bode, President and COO at Denny’s (DENN), recently bought 9,740 shares. The buy increased his stake by over 1,000%, and came to a total cost of $49,805. This marks the first insider buy since last June, when the company CFO bought 10,000 shares for just over $65,000. Going further back, insiders were more likely to be sellers, particularly in 2023, when shares traded for nearly twice as much as they do today. Overall, Denny’s insiders own 3.1% of shares. The diner chain ...
Read More About This

Charles Moorman, a director at Oracle (ORCL), recently bought 5,000 shares. The buy increased his stake by 7%, and came to a total cost of $947,913. This marks the first insider buy at the company in over two years. Otherwise, company insiders have been regular sellers of shares as the stock has taken off. Nearly all insider sales have come following the exercise of stock options, from company directors and VPs to the company’s CFO, and major holder Larry Ellison. Overall, Oracle ...
Read More About This

John Lindsay, President and CEO of Helmerich & Payne (HP), recently bought 20,000 shares. The buy increased his stake by 3%, and came to a total cost of $551,000. He was joined by a company director, who bought 37,356 shares for a hefty $1.01 million, increasing his position by a massive 217%. The company CFO bought 3,300 shares last year, starting a new position at a cost of just over $99,000. Otherwise, insiders have previously been sellers. Overall, Helmerich & Payne insiders ...
Read More About This

Philip Guido, an EVP at Advanced Micro Devices (AMD), recently bought 4,645 shares. The buy increased his stake by 16%, and came to a total cost of $499,616. This buy is the first insider activity of 2025. Insiders were only sellers of shares in 2024 and 2023. That included significant sales from the company CEO, usually following the exercise of stock options. The company CFO also sold over one-third of her position last June. Overall, Advanced Micro Devices insiders own 0.5% of ...
Read More About This

Berkshire Hathaway (BRK-B), a major holder of Occidental Petroleum (OXY), has continued to add to its stake with a 763,017 share buy. The most recent buy increased Berkshire’s position by less than 1%, and came to a total cost of $35,724,074. This is Berkshire’s first buy of the year, but the holding company last bought Occidental back in December, paying just over $409 million for almost 8.9 million shares. Berkshire has been the only insider to buy over the past two ...
Read More About This

Allan Merrill, President and CEO of Beazer Homes (BZH), recently bought 5,000 shares. The buy increased his position by less than 1%, and came to a total cost of $109,150. He was joined by the company’s general council, who bought 449 shares for just over $10,000, and a company director purchased 22,500 shares for a massive $510,379 in total. Insiders were slight sellers of shares last year when Beazer stock traded at a higher price. Overall, Beazer Homes insiders own 6.2% of ...
Read More About This